Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05901766

Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment

Effect of Maternal Supplementation With an Iodine-containing Multiple Micronutrient During Lactation on Infant Iodine Status, Thyroid Function and Neurodevelopment

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Brown University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn about the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers who live in settings with mild iodine deficiency. The main questions it aims to answer are: 1. What are the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers on infant development, as measured by electroencephalography/visual evoked potentials? 2. What are the effects of iodine-containing multiple micronutrient supplements on breast milk concentrations of iodine, and infant iodine and thyroid status? 3. How do iodine and iron interact with each other to affect thyroid function in the mother during lactation? Participants will be randomized to receive a daily multiple micronutrient tablet containing iodine (UNIMAPP) for 6 months postpartum, or routine postnatal care per Ethiopia Ministry of Health. Mothers will provide a breast milk sample and blood at 3 and 6 months postpartum. Infants will provide a urine sample and drop of blood, and have a neurodevelopmental assessment at 3 and 6 months. Researchers will compare the groups that received the iodine-containing micronutrient supplement with the group that received routine care and see if there were any benefits on infant development and iodine and thyroid status in the mother and baby.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTUNIMAP Multiple Micronutrient SupplementIodine Containing Multiple Micronutrient Supplement once daily

Timeline

Start date
2026-01-01
Primary completion
2026-12-30
Completion
2027-04-01
First posted
2023-06-13
Last updated
2025-09-29

Source: ClinicalTrials.gov record NCT05901766. Inclusion in this directory is not an endorsement.